An oversubscribed Series B financing round has pulled in $5 million for Kalamazoo, Mich.-based Innovative Cardiovascular Solutions, which makes the Emblok embolic protection system for use in structural heart procedures and transcatheter aortic valve replacement. The company will use the proceeds to further develop the device and launch a 510(k) study in the US.
Innovative Cardiovascular Solutions gets $5M boost
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.